B
보령
003850KOSPI의약품 제조업58.1 / 100
Reference Date: 2026-04-13
Financial Score20.0 / 40
News Sentiment13.1 / 25
Momentum15.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE significantly exceeds the industry average but the high debt ratio poses financial risk. Slightly up 1.8% over the past month, and news sentiment is positive.
Company InformationBased on 2025 Annual Report
Business Overview
Boehringer focuses on strengthening its own product portfolio and building a stable portfolio centered on chronic diseases to enhance profitability. In 2024, the company achieved sales of 1.171 trillion KRW and operating profit of 70.5 billion KRW. It leverages manufacturing competitiveness, R&D capabilities, sales and marketing strength, and the LBA strategy to maintain global market competitiveness.
Number of Employees
1,645people
Average Salary
72.1M KRW
Score Calculation Basis
Detailed Financial Score
PER
12.74Industry Average 14.805.0Point
In line with industry avg
PBR
0.99Industry Average 1.044.0Point
In line with industry avg
ROE
7.89Industry Average 4.425.5Point
1.8x industry avg (good)
Debt Ratio
33.99Industry Average 11.980.0Point
2.8x industry avg (risky)
Trend 2023~20255.5 / 10 points
Revenue Growth Rate
2.0 / 3
Avg ▲9.2% (2-year basis)
Operating Profit Growth Rate
0.5 / 3
Avg ▼2.2% (2-year basis)
ROE Trend
3.0 / 4
Avg ROE 8.6% (improving, 3yr)
Detailed News Sentiment
13 totalPositive 2Neutral 6Negative 0Average Sentiment Score 53.8
- Neutral
- Neutral
- Neutral
Detailed Momentum
52-week position6.0Point
52w upper range (63%)
Current 9,760Won52-week high 10,68052-week low 8,170
1-month return3.0Point
1m 1.77% (flat)
Volume trend6.0Point
Volume increasing
Detailed Disclosure
10 totalPositive 0Neutral 10Negative 0
- Neutral공정거래자율준수프로그램운영현황(안내공시)2026-04-06
- Neutral주식등의대량보유상황보고서(약식)2026-04-01
- Neutral정기주주총회결과2026-03-31
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
- Neutral[첨부정정]사업보고서 (2025.12)2026-03-27